106 related articles for article (PubMed ID: 3950066)
1. View from the Nation's Capital.
Appler WD
J Clin Psychopharmacol; 1986 Feb; 6(1):42-4. PubMed ID: 3950066
[No Abstract] [Full Text] [Related]
2. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Feb; 4(1):52-4. PubMed ID: 6096407
[No Abstract] [Full Text] [Related]
3. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Jun; 4(3):161-2. PubMed ID: 6096408
[No Abstract] [Full Text] [Related]
4. View from the nation's capital.
Romansky MA
J Clin Psychopharmacol; 1985 Feb; 5(1):51-2. PubMed ID: 2982923
[No Abstract] [Full Text] [Related]
5. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Oct; 4(5):288-9. PubMed ID: 6096409
[No Abstract] [Full Text] [Related]
6. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1983 Feb; 3(1):47-8. PubMed ID: 6680403
[No Abstract] [Full Text] [Related]
7. View from the Nation's Capitol.
Freishtat HW
J Clin Psychopharmacol; 1982 Apr; 2(2):146-8. PubMed ID: 6926924
[No Abstract] [Full Text] [Related]
8. View from the Nation's Capital. New drug application (NDA) and investigational new drug (IND) regulations.
Romansky MA
J Clin Psychopharmacol; 1983 Dec; 3(6):380-3. PubMed ID: 6680409
[No Abstract] [Full Text] [Related]
9. View from the Nation's Capital. Investigational new drug (IND) and new drug application (NDA).
Romansky MA
J Clin Psychopharmacol; 1983 Jun; 3(3):193-4. PubMed ID: 6680405
[No Abstract] [Full Text] [Related]
10. View from the Nation's Capital. FDA moves forward (and backwards) on a number of simmering issues.
Appler WD
J Clin Psychopharmacol; 1988 Feb; 8(1):57-8. PubMed ID: 3351001
[No Abstract] [Full Text] [Related]
11. View from the Nation's Capital.
Freishtat HW
J Clin Psychopharmacol; 1985 Apr; 5(2):117-9. PubMed ID: 3988970
[No Abstract] [Full Text] [Related]
12. View from the Nation's Capital. FDA challenged successfully on its policies regarding good manufacturing practice inspections of medical drug and device manufacturers.
Appler WD
J Clin Psychopharmacol; 1987 Oct; 7(5):346-7. PubMed ID: 3680606
[No Abstract] [Full Text] [Related]
13. View from the Nation's Capital.
Appler WD
J Clin Psychopharmacol; 1987 Aug; 7(4):268-9. PubMed ID: 3624511
[No Abstract] [Full Text] [Related]
14. View from the Nation's Capital. DEA considers relaxing restrictions on medical use of marijuana.
Appler WD; Beck DC
J Clin Psychopharmacol; 1988 Apr; 8(2):133-4. PubMed ID: 2897379
[No Abstract] [Full Text] [Related]
15. View from the Nation's Capital. Proposed legislation would extend medical device reporting requirements to health care facilities.
Appler WD
J Clin Psychopharmacol; 1988 Oct; 8(5):363-4. PubMed ID: 3183075
[No Abstract] [Full Text] [Related]
16. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1983 Oct; 3(5):319-21. PubMed ID: 6680407
[No Abstract] [Full Text] [Related]
17. View from the Nation's Capital. The battle over indirect costs.
Appler WD
J Clin Psychopharmacol; 1986 Aug; 6(4):240-2. PubMed ID: 3734144
[No Abstract] [Full Text] [Related]
18. View from the Nation's Capitol.
Romansky MA
J Clin Psychopharmacol; 1982 Feb; 2(1):74-5. PubMed ID: 6926923
[No Abstract] [Full Text] [Related]
19. View from the Nation's Capital.
Appler WD
J Clin Psychopharmacol; 1985 Dec; 5(6):350-2. PubMed ID: 4067003
[No Abstract] [Full Text] [Related]
20. View from the Nation's Capital. Animal research: public pressure versus research needs.
Appler WD
J Clin Psychopharmacol; 1986 Oct; 6(5):305-8. PubMed ID: 3771815
[No Abstract] [Full Text] [Related]
[Next] [New Search]